ArticleJournal of the American Geriatrics Society2026
Prolonged Use of Postoperative Gabapentin After Discharge From a Skilled Nursing Facility.
Article in Journal of the American Geriatrics Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe number of older adults being discharged to a skilled nursing facility (SNF) after surgery continues to rise. Prior studies have shown that gabapentinoid prescribing after surgery is increasing, though this work only studied patients transitioning from hospital to home. Therefore, we aim to describe both use and prolonged use of gabapentinoids for older adults who are discharged to SNF and then home after surgery.
methodsWe conducted a retrospective analysis by merging patient data from Medicare Carrier, MedPAR, and Outpatient Files with Medicare Part D for 2013-2020. We included patients ≥ 66 years at time of procedure undergoing one of 14 common surgeries performed in older adults whose discharge was to SNF then home.
resultsThe total study cohort included 79,417 patients who were discharged to a SNF. Median length of SNF stay was 15 days (IQR 10, 22 days). A total of 3182 (4%) received a new gabapentinoid prescription. Of these, 38% (n = 1219) had prolonged use. On multivariable logistic regression, we found that female sex, gabapentinoid days supply, emergency surgery, non-orthopedic and nonvascular surgery, and higher area deprivation index were associated with prolonged use.
conclusionsOf our cohort, 38% had prolonged use, more than 1.5 times the proportion of prolonged use found in a past study among patients being discharged directly home. Importantly, patients who were sicker and more disadvantaged were more likely to have prolonged use. Our study highlights that additional work needs to focus on understanding and preventing inappropriate prolonged use of gabapentinoids after SNF discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.